UR Medicine cardiologists are first in region to offer the world’s smallest pacemaker for people with irregular or slow heart rhythms. The Micra Transcatheter Pacing System is the most advanced technology available for people with bradycardia, a condition characterized by … Read More »
UMass Medical School scientist Gang Han, PhD, and his team have designed a new class of molecules used in photodynamic therapy that are able to direct lamp light deep into tissue to kill cancer tumors. In a new paper published … Read More »
Nanoscale fluorescent probes that switch on in the presence of cancer cells helped surgeons remove tumours in mice without harming healthy tissue, according to a study published Monday. The potentially breakthrough technology works for all kinds of cancers, the researchers … Read More »
The bionic pancreas system developed by Boston University (BU) investigators proved better than either conventional or sensor-augmented insulin pump therapy at managing blood sugar levels in patients with type 1 diabetes living at home, with no restrictions, over 11 days. … Read More »
Women today are choosing to have children later in life than ever before. Egg freezing, technically known as oocyte cryopreservation, can enable a woman to delay pregnancy until a later stage. In 1980, the average American woman had her first … Read More »
A recent study investigated the levels of specific DNA fragments in the blood of ovarian cancer patients. The findings could eventually lead to a blood test that can make accurate predictions about tumor size and disease progression. Detecting DNA fragments … Read More »
An analysis of English NHS hospitals suggests that employing private as opposed to in-house cleaners is a false economy. While it may reduce costs, it could also raise risk of infection by methicillin-resistant Staphylococcus aureus, a superbug responsible for life-threatening … Read More »
As 2017 arrives, many of us are thinking about the healthy lifestyle changes we want to make for the coming year. Do you plan to exercise more? Lose weight? Quit smoking? How about cutting down on alcohol intake? While that … Read More »
Alexion Pharmaceuticals quietly reported late Wednesday that its Phase 2/3 trial of eculizumab (Soliris) had failed to reach its primary endpoint for the prevention of delayed graft function in recipients of deceased donor kidneys. The news rounds out a tumultuous final … Read More »
PsiOxus Therapeutics has signed a second agreement with Bristol-Myers Squibb (BMS), this time for worldwide rights to its ‘armed’ oncolytic virus NG-348, currently in the preclinical research phase. The new deal comes six months after the two companies joined forces … Read More »